Learn from experts in the field on key issues for safe neuromuscular blockade and reversal. Discussion includes Intraoperative neuromuscular monitoring, dosing of reversal agents, and reversal strategies.
J. Ross Renew, MD, FASA, FASE, is currently an Assistant Professor of Anesthesiology and serves as the Vice Chair of Research for his department at the Mayo Clinic in Jacksonville, Florida. Dr. Renew completed his anesthesiology residency at Mayo Clinic in Jacksonville, Florida and his Adult Cardiothoracic Anesthesiology at Mayo Clinic in Rochester, Minnesota.
Dr. Renew is an active researcher and leads a team interested in neuromuscular blockade, neuromuscular blockade monitoring, and practical strategies to optimize neuromuscular blockade management. In addition to his research efforts, he serves as the Associate Residency Director and is passionate about educating the next generation of anesthesiologists on the best way to manage neuromuscular blockade.
Rachel C. Wolfe, PharmD, MHA, BCCCP, is Clinical Pharmacy Specialist of Perioperative and Surgical Critical Care at Barnes-Jewish Hospital and Washington University Medical Center in St. Louis, Missouri. She is also Adjunct Clinical Instructor for the Barnes-Jewish Hospital Goldfarb School of Nursing and St. Louis College of Pharmacy. , Dr. Wolfe is responsible for the provision of clinical pharmacy services in the perioperative and periprocedural environment and for the coordination of clinical services provided by four operating room pharmacy satellites. She also serves as a preceptor for Doctor of Pharmacy students and pharmacy residents and is co-chair of the Enhanced Surgical Recovery Pharmacy & Documentation committee and the Analgesia subcommittee of the Pharmacy & Therapeutics committee.
Dr. Wolfe earned her Doctor of Pharmacy degree from St. Louis College of Pharmacy and Master of Health Administration degree from Webster University, also in St. Louis. She completed her residency training at University of Kentucky HealthCare, and she is board certified in critical care.
Dr. Wolfe is a member of the American College of Clinical Pharmacy, American Society of Enhanced Recovery, and Society of Critical Care Medicine. In 2011 she received Barnes-Jewish Hospital’s David A. Gee Meritorious Service Award and Team Award for Quality Improvement for Anesthesia Medication Management.
Provided by ASHP
Supported by an educational grant from Merck